Washington, D.C., US – The USFood and Drug Administration has approved a pill version of the drug Wegovy from Novo Nordisk as a treatment for weight loss ... US-listed shares of Novo jumped 8% after the approval announcement for its Wegovy pill.
HYDERABAD, India - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year ... LILLY'S GAIN IS NOVO'S PAIN.
22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy. The once-daily tablet — called the Wegovy pill — is the first oral version of glucagon-like peptide-1 drugs, or GLP-1s, Novo Nordisk said in a news release.
The approval was based on the results of the Oasis 4 trial, which found people taking a 25 milligram pill once daily lost about 16.6% of their body weight ... .